Jump to content
RemedySpot.com

Hepatitis C Links to new Articles

Rate this topic


Guest guest

Recommended Posts

News new results for Hepatitis IMS revises Incivek drug data; Vertex shares

jump

Reuters

Incivek is one of two recently-launched hepatitis C drugs. It competes with

Victrelis, made by Merck & Co . Both drugs promise a higher cure rate for the

disease, which infects the liver and can lead eventually to cirrhosis and liver

failure. ...

See all stories on this topic »Anadys achieves positive interim results in

ongoing phase 2b hepatitis C study

Proactive Investors USA & Canada

Anadys Pharmaceuticals (NASDAQ:ANDS) announced Thursday positive interim results

in its ongoing phase 2b study of setrobuvir, in combination with pegylated

interferon and ribavirin (P/R), in patients with the hepatitis C virus. ...

See all stories on this topic »

Hepatitis warning to Japanese diners

ABC Online

A public health warning has been issued after a staff member of a Japanese

restaurant in Adelaide was diagnosed with hepatitis A. People who ate at the

Yakitori Takumi restaurant in Melbourne Street at North Adelaide between

September 21 and October 4 ...

See all stories on this topic »Worker at popular Yakatori Takumi restaurant

contracts Hepatitis A

NEWS.com.au

A FOOD handler at a North Adelaide restaurant has contracted Hepatitis A,

forcing SA Health to issue a public health alert. Chief Medical Officer

Professor Paddy said the food handler worked at Yakatori Takumi

restaurant on Melbourne St and ...

See all stories on this topic »Achillion Announces Nomination of Second

Generation NS5A Inhibitor for the ...

MarketWatch (press release)

" Inhibition of the NS5A target is one of the most compelling approaches to

treating hepatitis C. With the development of this second generation compound,

ACH-3102, with its improved antiviral activity and potency, we continue to

deliver on our ...

See all stories on this topic »Hepatitis C Medication Adherence Is an Important

Challenge, Study Shows

AIDSmeds.com HIV/AIDS Treatment News

Identifying and overcoming barriers to hepatitis C medication adherence is an

essential component to treatment strategies, according to study results

published online by ls of Internal Medicine. Patients being treated for

chronic hepatitis C become ...

See all stories on this topic »UC San Diego School of Medicine Launches

Hepatitis C Clinical Trials

UCSD Medical Center

A collaborative partnership between the UC San Diego Liver Center and Antiviral

Research Center (AVRC) has resulted in 19 clinical trials for hepatitis C virus

(HCV), focused on developing more effective and well-tolerated HCV treatments.

....

See all stories on this topic »Hepatitis C verdict misplaces blame

Las Vegas Sun

What a shame that the jurors in the recent hepatitis C outbreak case awarded

$162.5 million in punitive damages to the three people infected. The actions of

today's jurors to hand out ridiculous amounts in these cases does nothing but

drive up the ...

See all stories on this topic »Inovio, VGX ink hep B and C vaccine deal

FierceVaccines

Blue Bell, PA-based Inovio Pharmaceuticals and VGX International will

collaborate on the development of Inovio's synthetic vaccines for hepatitis B

and hepatitis C. Financial details of the deal were not disclosed. Inovio's

SynCon vaccine technology ...

See all stories on this topic »

Link to comment
Share on other sites

Join the conversation

You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.

Guest
Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

Loading...
×
×
  • Create New...